NICE-SUGAR trial


  • clinical question: in icu patients, does intensive glycemic control reduce mortality compared to conventional control
    • primary: 90 day mortality, hypoglycemic events
  • bottom line: intensive control (81-108) leads to higher mortality compared to conventional control (<180)